A long-lasting response to sorafenib treatment in an advanced hepatocellular carcinoma patient(639 views) Di Lorenzo G, Imbimbo M, Leopardo D, Marciano R, Federico P, Buonerba C, Salvatore B, Marinelli A, Palmieri G. A
Int J Immunopathol Pharmacol (ISSN: 0394-6320), 2010 Jul; 23(3): 951-954.
Keywords: Advanced Disease, Hepatocellular Carcinoma, Sorafenib, Adult, Advanced Cancer, Article, Cancer Survival, Case Report, Chemoembolization, Drug Dose Reduction, Drug Efficacy, Drug Withdrawal, Febrile Neutropenia, Follow Up, Hand Foot Syndrome, Heart Infarction, Human, Human Tissue, Liver Biopsy, Liver Cell Carcinoma, Multiple Cycle Treatment, Priority Journal, Progression Free Survival, Treatment Response, Treatment Withdrawal, Antineoplastic Agents, Benzenesulfonates, Disease Progression, Liver Neoplasms, Middle Aged, Myocardial Infarction, Pyridines, Tumor Markers, Biological,
Affiliations: *** IBB - CNR ***
Department of Endocrinology and Clinical Oncology, Referential Rare Tumors Center, University Federico II, Naples, Italy
Radiology Division, University Federico II, Naples, Italy
References: Not available.
A long-lasting response to sorafenib treatment in an advanced hepatocellular carcinoma patient